Baucus Re-Introduces Comparative Effectiveness Bill, Adds “Safeguards” Between CER And Coverage Decisions
This article was originally published in The Pink Sheet Daily
Executive Summary
Finance Committee chairman would require opportunity for stakeholder comments, consideration of other research before CER results are used to revise HHS health coverage policy.
You may also be interested in...
PCORI In Brief: New Board Member, Funding Opportunities
The Patient-Centered Outcomes Research Institute welcomes UCSF professor Alicia Fernandez to the board, announces pragmatic trials funding opportunity; Senate bids farewell to PCORI champion Max Baucus.
CER Just “A Piece Of The Pie” In Driving Quality, Cost-Efficient Care
With the emphasis that is being given to comparative effectiveness research in the context of the current health care reform debate, industry stakeholders are cautioning that while it is a component of overall reform, it is not going to be a silver bullet that will drive lower costs
CER Just “A Piece Of The Pie” In Driving Quality, Cost-Efficient Care
With the emphasis that is being given to comparative effectiveness research in the context of the current health care reform debate, industry stakeholders are cautioning that while it is a component of overall reform, it is not going to be a silver bullet that will drive lower costs